CONMED CORP (CNMD) Stock Fundamental Analysis
USA • New York Stock Exchange • NYSE:CNMD • US2074101013
39.93 USD
+1.14 (+2.94%)
At close: Feb 4, 2026
39.93 USD
0 (0%)
After Hours: 2/4/2026, 8:11:47 PM
We assign a fundamental rating of 5 out of 10 to CNMD. CNMD was compared to 186 industry peers in the Health Care Equipment & Supplies industry. CNMD has an average financial health and profitability rating. CNMD scores decently on growth, while it is valued quite cheap. This could make an interesting combination.
1. Profitability
1.1 Basic Checks
- CNMD had positive earnings in the past year.
- CNMD had a positive operating cash flow in the past year.
- Of the past 5 years CNMD 4 years were profitable.
- CNMD had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- CNMD's Return On Assets of 2.77% is fine compared to the rest of the industry. CNMD outperforms 76.88% of its industry peers.
- CNMD's Return On Equity of 6.38% is amongst the best of the industry. CNMD outperforms 80.11% of its industry peers.
- With a decent Return On Invested Capital value of 4.94%, CNMD is doing good in the industry, outperforming 76.34% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.77% | ||
| ROE | 6.38% | ||
| ROIC | 4.94% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin of CNMD (4.77%) is better than 77.42% of its industry peers.
- CNMD's Profit Margin has improved in the last couple of years.
- Looking at the Operating Margin, with a value of 9.99%, CNMD is in the better half of the industry, outperforming 78.49% of the companies in the same industry.
- CNMD's Operating Margin has improved in the last couple of years.
- With a Gross Margin value of 54.22%, CNMD perfoms like the industry average, outperforming 52.15% of the companies in the same industry.
- CNMD's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.99% | ||
| PM (TTM) | 4.77% | ||
| GM | 54.22% |
OM growth 3Y15.88%
OM growth 5Y7.91%
PM growth 3YN/A
PM growth 5Y25.45%
GM growth 3Y1.06%
GM growth 5Y0.77%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CNMD is destroying value.
- CNMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- An Altman-Z score of 1.84 indicates that CNMD is not a great score, but indicates only limited risk for bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 1.84, CNMD is in line with its industry, outperforming 58.60% of the companies in the same industry.
- The Debt to FCF ratio of CNMD is 5.74, which is a neutral value as it means it would take CNMD, 5.74 years of fcf income to pay off all of its debts.
- CNMD has a Debt to FCF ratio of 5.74. This is in the better half of the industry: CNMD outperforms 77.96% of its industry peers.
- A Debt/Equity ratio of 0.85 indicates that CNMD is somewhat dependend on debt financing.
- The Debt to Equity ratio of CNMD (0.85) is worse than 72.58% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.85 | ||
| Debt/FCF | 5.74 | ||
| Altman-Z | 1.84 |
ROIC/WACC0.55
WACC9.03%
2.3 Liquidity
- A Current Ratio of 2.10 indicates that CNMD has no problem at all paying its short term obligations.
- CNMD has a Current ratio (2.10) which is comparable to the rest of the industry.
- A Quick Ratio of 0.95 indicates that CNMD may have some problems paying its short term obligations.
- The Quick ratio of CNMD (0.95) is worse than 77.96% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.1 | ||
| Quick Ratio | 0.95 |
3. Growth
3.1 Past
- CNMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.82%, which is quite good.
- CNMD shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 16.37% yearly.
- Looking at the last year, CNMD shows a small growth in Revenue. The Revenue has grown by 5.18% in the last year.
- The Revenue has been growing by 9.77% on average over the past years. This is quite good.
EPS 1Y (TTM)10.82%
EPS 3Y20.27%
EPS 5Y16.37%
EPS Q2Q%6.72%
Revenue 1Y (TTM)5.18%
Revenue growth 3Y9.55%
Revenue growth 5Y9.77%
Sales Q2Q%7.88%
3.2 Future
- CNMD is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.09% yearly.
- CNMD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.55% yearly.
EPS Next Y-1.76%
EPS Next 2Y4.92%
EPS Next 3Y7.09%
EPS Next 5YN/A
Revenue Next Year0.29%
Revenue Next 2Y2.72%
Revenue Next 3Y3.55%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 8.66, which indicates a very decent valuation of CNMD.
- 95.70% of the companies in the same industry are more expensive than CNMD, based on the Price/Earnings ratio.
- Compared to an average S&P500 Price/Earnings ratio of 28.25, CNMD is valued rather cheaply.
- Based on the Price/Forward Earnings ratio of 8.82, the valuation of CNMD can be described as reasonable.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of CNMD indicates a rather cheap valuation: CNMD is cheaper than 96.77% of the companies listed in the same industry.
- Compared to an average S&P500 Price/Forward Earnings ratio of 27.50, CNMD is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.66 | ||
| Fwd PE | 8.82 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CNMD indicates a rather cheap valuation: CNMD is cheaper than 91.40% of the companies listed in the same industry.
- Based on the Price/Free Cash Flow ratio, CNMD is valued cheaper than 98.92% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.32 | ||
| EV/EBITDA | 9.66 |
4.3 Compensation for Growth
- The decent profitability rating of CNMD may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.53
EPS Next 2Y4.92%
EPS Next 3Y7.09%
5. Dividend
5.1 Amount
- CNMD has a Yearly Dividend Yield of 2.04%. Purely for dividend investing, there may be better candidates out there.
- Compared to an average industry Dividend Yield of 0.21, CNMD pays a better dividend. On top of this CNMD pays more dividend than 96.24% of the companies listed in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.82, CNMD has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.04% |
5.2 History
- The dividend of CNMD decreases each year by -0.01%.
- CNMD has been paying a dividend for at least 10 years, so it has a reliable track record.
- CNMD has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-0.01%
Div Incr Years0
Div Non Decr Years12
5.3 Sustainability
- 39.73% of the earnings are spent on dividend by CNMD. This is a low number and sustainable payout ratio.
DP39.73%
EPS Next 2Y4.92%
EPS Next 3Y7.09%
39.93
+1.14 (+2.94%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-28 2026-01-28/amc
Earnings (Next)04-28 2026-04-28/amc
Inst Owners114.3%
Inst Owner Change-0.54%
Ins Owners0.29%
Ins Owner Change0.35%
Market Cap1.24B
Revenue(TTM)1.37B
Net Income(TTM)64.32M
Analysts73.33
Price Target49.57 (24.14%)
Short Float %7.55%
Short Ratio3.66
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.04% |
Yearly Dividend0.8
Dividend Growth(5Y)-0.01%
DP39.73%
Div Incr Years0
Div Non Decr Years12
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.52%
Min EPS beat(2)0.37%
Max EPS beat(2)0.66%
EPS beat(4)4
Avg EPS beat(4)6.26%
Min EPS beat(4)0.37%
Max EPS beat(4)14.78%
EPS beat(8)7
Avg EPS beat(8)4.08%
EPS beat(12)10
Avg EPS beat(12)-0.4%
EPS beat(16)13
Avg EPS beat(16)0.52%
Revenue beat(2)0
Avg Revenue beat(2)-0.89%
Min Revenue beat(2)-1.03%
Max Revenue beat(2)-0.75%
Revenue beat(4)1
Avg Revenue beat(4)-0.45%
Min Revenue beat(4)-1.03%
Max Revenue beat(4)0.51%
Revenue beat(8)1
Avg Revenue beat(8)-1.24%
Revenue beat(12)3
Avg Revenue beat(12)-1.58%
Revenue beat(16)4
Avg Revenue beat(16)-1.61%
PT rev (1m)0%
PT rev (3m)-21.62%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.42%
EPS NY rev (1m)0%
EPS NY rev (3m)0.73%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.62%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.07%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.66 | ||
| Fwd PE | 8.82 | ||
| P/S | 0.92 | ||
| P/FCF | 8.32 | ||
| P/OCF | 7.39 | ||
| P/B | 1.23 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.66 |
EPS(TTM)4.61
EY11.55%
EPS(NY)4.53
Fwd EY11.34%
FCF(TTM)4.8
FCFY12.02%
OCF(TTM)5.4
OCFY13.53%
SpS43.51
BVpS32.56
TBVpS-12.65
PEG (NY)N/A
PEG (5Y)0.53
Graham Number58.11
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.77% | ||
| ROE | 6.38% | ||
| ROCE | 6.7% | ||
| ROIC | 4.94% | ||
| ROICexc | 5.04% | ||
| ROICexgc | 17.43% | ||
| OM | 9.99% | ||
| PM (TTM) | 4.77% | ||
| GM | 54.22% | ||
| FCFM | 11.04% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y15.88%
OM growth 5Y7.91%
PM growth 3YN/A
PM growth 5Y25.45%
GM growth 3Y1.06%
GM growth 5Y0.77%
F-Score5
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.85 | ||
| Debt/FCF | 5.74 | ||
| Debt/EBITDA | 4.09 | ||
| Cap/Depr | 25.13% | ||
| Cap/Sales | 1.38% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 80.15% | ||
| Profit Quality | 231.2% | ||
| Current Ratio | 2.1 | ||
| Quick Ratio | 0.95 | ||
| Altman-Z | 1.84 |
F-Score5
WACC9.03%
ROIC/WACC0.55
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.82%
EPS 3Y20.27%
EPS 5Y16.37%
EPS Q2Q%6.72%
EPS Next Y-1.76%
EPS Next 2Y4.92%
EPS Next 3Y7.09%
EPS Next 5YN/A
Revenue 1Y (TTM)5.18%
Revenue growth 3Y9.55%
Revenue growth 5Y9.77%
Sales Q2Q%7.88%
Revenue Next Year0.29%
Revenue Next 2Y2.72%
Revenue Next 3Y3.55%
Revenue Next 5YN/A
EBIT growth 1Y-35.26%
EBIT growth 3Y26.95%
EBIT growth 5Y18.45%
EBIT Next Year29.61%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-10.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-7.2%
OCF growth 3YN/A
OCF growth 5YN/A
CONMED CORP / CNMD FAQ
What is the ChartMill fundamental rating of CONMED CORP (CNMD) stock?
ChartMill assigns a fundamental rating of 5 / 10 to CNMD.
Can you provide the valuation status for CONMED CORP?
ChartMill assigns a valuation rating of 7 / 10 to CONMED CORP (CNMD). This can be considered as Undervalued.
How profitable is CONMED CORP (CNMD) stock?
CONMED CORP (CNMD) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for CNMD stock?
The Price/Earnings (PE) ratio for CONMED CORP (CNMD) is 8.66 and the Price/Book (PB) ratio is 1.23.
What is the expected EPS growth for CONMED CORP (CNMD) stock?
The Earnings per Share (EPS) of CONMED CORP (CNMD) is expected to decline by -1.76% in the next year.